← Back to all trials
Terminated
NCT04698564
Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging
Conditions: Prostate Cancer
Sex: Male
Ages: 40 Years – 80 Years
Healthy volunteers: No
Phase: PHASE2
Enrollment: 4
Sponsor: University of Maryland, Baltimore
Location: University of Maryland Medical Center Baltimore Maryland
Summary
This is a two-tiered pilot study in which there will be no randomization and no placebo treatment. This study will be to perform metabolic magnetic resonance imaging on men suspected to have a prostate cancer to understand if metabolic MRI can be safely performed on this population
Eligibility Criteria
Inclusion Criteria:
1. Age greater than 40 and less than 80 years
2. Clinical suspicion or history of prostate cancer reflected by one of the following:
* PSA \> 4ng/ml
* Abnormal DRE exam
* Known tissue diagnosis of prostate cancer from prior workup
3. Patient planning to undergo either a MRI targeted biopsy or radical prostatectomy for prostate cancer workup or treatment
Exclusion Criteria:
1. Inability to undergo MRI scan
2. Inability to receive IV contrast as per institutional protocol.
Source: ClinicalTrials.gov (NCT04698564). StuddyBuddy aggregates publicly available trial information.
